Search results
Results from the WOW.Com Content Network
A week ago, Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) came out with a strong set of annual numbers that could... Ionis Pharmaceuticals, Inc. Just Beat Analyst Forecasts, And Analysts Have Been ...
US stocks were mostly higher on Tuesday, led by the tech sector. Today marks the start of the Santa Claus trading window, a historically bullish 7-day stretch. The stock market will close at 1 p.m ...
For premium support please call: 800-290-4726 more ways to reach us
Last week's initial jobless claims came in at 219,000, below consensus estimates of 225,000. This month's deepening bond sell-off also comes as a reaction to hawkish signals from the Federal Reserve.
Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics.The company has three commercially approved medicines: Spinraza (), Tegsedi (), and Waylivra (Volanesorsen), and has four drugs in pivotal studies: tominersen for Huntington's disease (together with Roche), tofersen for SOD1-ALS, AKCEA ...
Ionis Pharmaceuticals Stock Price And Volume Action Ionis Pharmaceuticals (NASDAQ:IONS) is currently down 17.47% to a price of $46.29. Tuesday the stock has been traded at a volume of 2.55 million ...
Trading on the New York Stock Exchange will end mid-day Tuesday, with markets being closed through Christmas Day. Here's where US indexes stood shortly after the 9:30 a.m. opening bell on Monday ...
Get answers to your AOL Mail, login, Desktop Gold, AOL app, password and subscription questions. Find the support options to contact customer care by email, chat, or phone number.